Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

ROLE OF SERUM GLYPICAN-3 (GPC-3) IN EARLY DETECTION OF HEPATOCELLULAR CARCENOMA

Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study

EXPRESSION OF GLYPICAN-3(GPC-3) AND 8-HYDROXYDEOXYGUANOSINE (8-OHDG) IN CHRONIC HEPATITIS C AND RELATIONSHIP WITH HEPATOCELLULAR CARCINOMA

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

Role Of Serum Glypican 3 As A Predictive Tool For Early Diagnosis Of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

A COMPARATIVE STUDY OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF GOLGI PROTEIN 73 AND ALFA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA BEFORE AND AFTER THERAPEUTIC INTERVENTION

STUDY OF OSTEOPONTIN AS A NOVELTUMOR MARKER FOR DETECTION OF HEPATOCELLULAR CARCINOMA